Transfer RNAs at the heart of therapeutic resistance
An international research team led by scientists from the University of Liège has discovered an interesting new therapeutic target for the treatment of melanoma resistant to targeted therapies. Inhibition of the VARS enzyme could prevent this therapeutic resistance by resensitising tumours resistant to these targeted therapies. Melanoma is one of the most serious and aggressive … Read more
